학술논문
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
Document Type
Article
Author
Source
In Kidney International Reports November 2022 7(11):2345-2355
Subject
Language
ISSN
2468-0249